Aethlon Medical (AEMD) Shares Outstanding (Diluted Average) (2010 - 2026)

Aethlon Medical's Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $673945.0 for Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 331.78% year-over-year to $673945.0; the trailing twelve-month figure through Mar 2026 stood at $673945.0 (up 331.78% YoY), and the FY2026 full-year result was $673945.0, up 331.78% from the prior year.
• Shares Outstanding (Diluted Average) was $673945.0 for Q1 2026 at Aethlon Medical, down from $823126.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Diluted Average) for AEMD reached as high as $15.5 million in Q2 2022 and fell as low as $133944.0 in Q3 2024.
• Median Shares Outstanding (Diluted Average) over the past 5 years was $1.8 million (2022), compared with a mean of $2.9 million.
• Across the five-year window, Shares Outstanding (Diluted Average) slumped 94.61% in 2024 and jumped 371.63% in 2025, its largest moves.
• Over 5 years, Shares Outstanding (Diluted Average) stood at $2.0 million in 2022, then advanced by 27.47% to $2.5 million in 2023, then plunged by 93.06% to $174529.0 in 2024, then surged by 371.63% to $823126.0 in 2025, then fell by 18.12% to $673945.0 in 2026.
• Business Quant data shows AEMD's Shares Outstanding (Diluted Average) at $673945.0 in Q1 2026, $823126.0 in Q4 2025, and $304960.0 in Q3 2025.